AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 31127302 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent intervention (MI)
Number of subjects: 1442
Study 31127302 — intervention group
Group type: COMPARATOR
Intervention: Educational intervention (EI)
Number of subjects: 1442
Study 30959189 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 20,000 IU per week
Number of subjects: 399
Study 30959189 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 399
Study 28662406 — intervention group
Group type: EXPERIMENTAL
Intervention: Eribulin in combination with pertuzumab and trastuzumab
Number of subjects: 30
Study 26302914 — intervention group
Group type: EXPERIMENTAL
Intervention: 600μg/day CrPic supplementation
Number of subjects: 71
Study 26302914 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 71
Study 24206407 — intervention group
Group type: EXPERIMENTAL
Intervention: Ardeh 28 g/d (two tablespoons) for six weeks
Number of subjects: 41
Study 24206407 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual breakfast)
Number of subjects: 41
Study 20508540 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric exercise
Number of subjects: 20
Study 20508540 — intervention group
Group type: COMPARATOR
Intervention: Concentric exercise
Number of subjects: 20
Study 18636232 — intervention group
Group type: COMPARATOR
Intervention: Intensive insulin therapy (IIT) alone
Number of subjects: 21
Study 18636232 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive insulin therapy combined with metformin (IIT+MET)
Number of subjects: 21
Study 16556716 — intervention group
Group type: EXPERIMENTAL
Intervention: GH therapy
Number of subjects: 55
Study 16556716 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study 12907461 — intervention group
Group type: EXPERIMENTAL
Intervention: Training group
Number of subjects: 67
Study 12907461 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 67
Study 11008354 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin 500 mg od, Amoxycillin 750 mg tid, Omeprazole 20 mg (Group A)
Number of subjects: 54
Study 11008354 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin 500 mg od, Amoxycillin 750 mg tid, Omeprazole 40 mg (Group B)
Number of subjects: 54
Study 11008354 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall treatment (both groups)
Number of subjects: 54
Study 8797481 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic manganese exposure (mean duration 20.25 years)
Number of subjects: 59
Study 8797481 — intervention group
Group type: COMPARATOR
Intervention: Control group (never worked in Mn mines or had short-term Mn employment)
Number of subjects: 59
Study 2062155 — intervention group
Group type: EXPERIMENTAL
Intervention: Electromyographic feedback with mirror feedback
Number of subjects: 25
Study 2062155 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirror feedback alone
Number of subjects: 25
Study 2062155 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 25
Study 6836233 — intervention group
Group type: EXPERIMENTAL
Intervention: Triamcinolone hexacetoide (TH)
Number of subjects: 24
Study 6836233 — intervention group
Group type: COMPARATOR
Intervention: Methylprednisolone (MP)
Number of subjects: 24
Study 3960427 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative irrigation with cefamandole nafate
Number of subjects: 208
Study 3960427 — intervention group
Group type: COMPARATOR
Intervention: Perioperative intravenous cefamandole
Number of subjects: 208
Study 29786471 — intervention group
Group type: EXPERIMENTAL
Intervention: EGCG+RES (epigallocatechin‐gallate 282 mg/d, resveratrol 80 mg/d)
Number of subjects: 25
Study 29786471 — intervention group
Group type: COMPARATOR
Intervention: PLA (placebo)
Number of subjects: 25
Study 27174221 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrative medicine rehabilitation (IMR)
Number of subjects: 360
Study 27174221 — intervention group
Group type: COMPARATOR
Intervention: Conventional rehabilitation (CR)
Number of subjects: 360
Study 25380624 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual conditioning stimuli
Number of subjects: 0
Study 25380624 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory conditioning stimuli
Number of subjects: 0
Study 25380624 — intervention group
Group type: EXPERIMENTAL
Intervention: Gustatory conditioning stimuli
Number of subjects: 0
Study 25380624 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined conditioning stimuli
Number of subjects: 0
Study 22832151 — intervention group
Group type: EXPERIMENTAL
Intervention: ST peak during primary PCI
Number of subjects: 363
Study 21077420 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced aesthetics dentures
Number of subjects: 0
Study 21077420 — intervention group
Group type: COMPARATOR
Intervention: Standard dentures (control)
Number of subjects: 0
Study 18713919 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicone wire‐reinforced tube
Number of subjects: 63
Study 18713919 — intervention group
Group type: COMPARATOR
Intervention: Parker tube
Number of subjects: 63
Study 18713919 — intervention group
Group type: COMPARATOR
Intervention: PVC tube
Number of subjects: 63
Study 18713919 — intervention group
Group type: COMPARATOR
Intervention: Parker tube after manipulation
Number of subjects: 63
Study 18713919 — intervention group
Group type: COMPARATOR
Intervention: PVC tube after manipulation
Number of subjects: 63
Study 18713919 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicone wire‐reinforced tube vs Parker tube after manipulation
Number of subjects: 63
Study 18713919 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicone wire‐reinforced tube vs PVC tube
Number of subjects: 63
Study 18713919 — intervention group
Group type: EXPERIMENTAL
Intervention: Parker tube vs PVC tube
Number of subjects: 63
Study 15933276 — intervention group
Group type: EXPERIMENTAL
Intervention: Professional long-term care
Number of subjects: 3107
Study 15933276 — intervention group
Group type: EXPERIMENTAL
Intervention: Transitions to professional home care or institutional care
Number of subjects: 3107
Study 15933276 — intervention group
Group type: COMPARATOR
Intervention: Transitions from professional home care or institutional care to no care or informal care only
Number of subjects: 3107
Study 12887843 — intervention group
Group type: COMPARATOR
Intervention: Iron syrup (Group A)
Number of subjects: 200
Study 12887843 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron powder sprinkled over food (Group B)
Number of subjects: 200
Study 12887843 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 200
Study 10473961 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical retinaldehyde
Number of subjects: 0
Study 8574720 — intervention group
Group type: EXPERIMENTAL
Intervention: Zaldaride 20 mg four times daily
Number of subjects: 436
Study 8574720 — intervention group
Group type: EXPERIMENTAL
Intervention: Zaldaride 2 x 20 mg as initial loading dose followed by three doses of 20 mg on the first day and four doses of 20 mg on the second day
Number of subjects: 436
Study 8574720 — intervention group
Group type: COMPARATOR
Intervention: Loperamide 2 x 2 mg loading dose followed by a flexible dosage of 2 mg after each unformed stool (maximum of 16 mg daily)
Number of subjects: 436
Study 8574720 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 436
Study 8574720 — intervention group
Group type: EXPERIMENTAL
Intervention: Zaldaride without a loading dose
Number of subjects: 436
Study 1960058 — intervention group
Group type: EXPERIMENTAL
Intervention: Rose coloured tint
Number of subjects: 20
Study 1960058 — intervention group
Group type: COMPARATOR
Intervention: Blue tint
Number of subjects: 20
Study 7084497 — intervention group
Group type: EXPERIMENTAL
Intervention: P vaginal suppositories
Number of subjects: 44
Study 7084497 — intervention group
Group type: EXPERIMENTAL
Intervention: Dehydrogesterone
Number of subjects: 44
Study 7084497 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 44
Study 30811541 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofogliflozin
Number of subjects: 774
Study 30082572 — intervention group
Group type: EXPERIMENTAL
Intervention: ECG-guided tip location technique
Number of subjects: 0
Study 30082572 — intervention group
Group type: COMPARATOR
Intervention: Traditional chest radiography tip location technique
Number of subjects: 0
Study 29871066 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT) with standardized dermatophagoides farinae extracts for 1 year
Number of subjects: 130
Study 29871066 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT)
Number of subjects: 130
Study 29871066 — intervention group
Group type: COMPARATOR
Intervention: Control group (no SLIT)
Number of subjects: 130
Study 23269476 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile-bearing surfaces
Number of subjects: 149
Study 23269476 — intervention group
Group type: COMPARATOR
Intervention: Fixed bearings
Number of subjects: 149
Study 21909728 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-weekly resistance training
Number of subjects: 155
Study 21909728 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice-weekly resistance training
Number of subjects: 155
Study 21909728 — intervention group
Group type: COMPARATOR
Intervention: Balance and tone classes
Number of subjects: 155
Study 21229700 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacokinetic simulation program (P (+) group)
Number of subjects: 79
Study 21229700 — intervention group
Group type: COMPARATOR
Intervention: No pharmacokinetic simulation program (P (−) group)
Number of subjects: 79
Study 21229700 — intervention group
Group type: COMPARATOR
Intervention: No pharmacokinetic simulation program (C group)
Number of subjects: 79
Study 16969657 — intervention group
Group type: EXPERIMENTAL
Intervention: Carisolv system
Number of subjects: 0
Study 16969657 — intervention group
Group type: COMPARATOR
Intervention: Hand excavation method
Number of subjects: 0
Study 16174589 — intervention group
Group type: EXPERIMENTAL
Intervention: Guliu capsule (GLC) combined with 89Sr
Number of subjects: 50
Study 16174589 — intervention group
Group type: COMPARATOR
Intervention: 89Sr alone
Number of subjects: 50
Study 11527250 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (BDP) at 1,600 microg/day or 800 microg/day + pranlukast (450 mg/day)
Number of subjects: 80
Study 11527250 — intervention group
Group type: EXPERIMENTAL
Intervention: Pranlukast (450 mg/day) with BDP at 800 microg/day (group I)
Number of subjects: 80
Study 11527250 — intervention group
Group type: EXPERIMENTAL
Intervention: Pranlukast (450 mg/day) with BDP at 1,600 microg/day (group II)
Number of subjects: 80
Study 11527250 — intervention group
Group type: COMPARATOR
Intervention: Pranlukast (450 mg/day) with BDP at 1,600 microg/day + 5 to 20 mg prednisolone (group III)
Number of subjects: 80
Study 11527250 — intervention group
Group type: EXPERIMENTAL
Intervention: Pranlukast (450 mg/day) with BDP introduced within the first year of onset of asthma
Number of subjects: 80
Study 9250457 — intervention group
Group type: EXPERIMENTAL
Intervention: Clamped hyperinsulinemic hypoglycemia (60 mU.m‐2.min‐1) at 2.8 mmol/l
Number of subjects: 8
Study 9250457 — intervention group
Group type: COMPARATOR
Intervention: Euglycemia at 5.0 mmol/l
Number of subjects: 8
Study 8421951 — intervention group
Group type: EXPERIMENTAL
Intervention: THAM plus hyperventilation
Number of subjects: 0
Study 8421951 — intervention group
Group type: COMPARATOR
Intervention: Hyperventilation alone
Number of subjects: 0
Study 8421951 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment specified)
Number of subjects: 0
Study 8421951 — intervention group
Group type: EXPERIMENTAL
Intervention: THAM
Number of subjects: 0
Study 3307582 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous heparin (initial dose of 15,000 U, adjusted thereafter)
Number of subjects: 103
Study 3307582 — intervention group
Group type: COMPARATOR
Intervention: Intravenous heparin (bolus injection of 5000 U, followed by an infusion of 1250 U/h, adjusted)
Number of subjects: 103
Study 31483005 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge on food crops
Number of subjects: 3414
Study 31483005 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased monthly availability of fruits at households
Number of subjects: 3414
Study 31483005 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater variety of fruits in commercial establishments
Number of subjects: 3414
Study 31483005 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of vegetables in commercial establishments
Number of subjects: 3414
Study 31483005 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater variety of fruits
Number of subjects: 3414
Study 28395207 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT-I); 2 in-person sessions (20-40 min) and 2 telephone sessions (15-20 min)
Number of subjects: 27
Study 28395207 — intervention group
Group type: COMPARATOR
Intervention: Sleep Hygiene (SH); 1 in-person session and 1 telephone session
Number of subjects: 27
Study 26261259 — intervention group
Group type: EXPERIMENTAL
Intervention: FOLFIRI plus cetuximab (arm A)
Number of subjects: 592
Study 26261259 — intervention group
Group type: COMPARATOR
Intervention: FOLFIRI plus bevacizumab (arm B)
Number of subjects: 592
Study 22906565 — intervention group
Group type: EXPERIMENTAL
Intervention: Purified anthocyanin mixture (320 mg/d)
Number of subjects: 150
Study 22906565 — intervention group
Group type: COMPARATOR
Intervention: Delphinidin-3-Ο-β-glucoside (Dp-3g)
Number of subjects: 150
Study 22906565 — intervention group
Group type: COMPARATOR
Intervention: Cyanidin-3-Ο-β-glucoside (Cy-3g)
Number of subjects: 150
Study 21493326 — intervention group
Group type: EXPERIMENTAL
Intervention: Tragal pumping on the experimental ear
Number of subjects: 24
Study 21493326 — intervention group
Group type: COMPARATOR
Intervention: Control ear (no tragal pumping)
Number of subjects: 24
Study 19290531 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin (3 mg/kg per dose 4 times daily)
Number of subjects: 30
Study 19290531 — intervention group
Group type: COMPARATOR
Intervention: Control (no erythromycin)
Number of subjects: 30
Study 16681761 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg/day of indole-3-carbinol (I3C)
Number of subjects: 12
Study 16681761 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg/day of indole-3-carbinol (I3C)
Number of subjects: 12
Study 16681761 — intervention group
Group type: EXPERIMENTAL
Intervention: indole-3-carbinol (I3C)
Number of subjects: 12
Study 15296681 — intervention group
Group type: EXPERIMENTAL
Intervention: Quick method of scoring the RTCQ
Number of subjects: 165
Study 15296681 — intervention group
Group type: EXPERIMENTAL
Intervention: Refined method of scoring the RTCQ
Number of subjects: 165
Study 15296681 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous readiness scale of scoring the RTCQ
Number of subjects: 165
Study 15296681 — intervention group
Group type: EXPERIMENTAL
Intervention: All three methods of scoring the RTCQ
Number of subjects: 165
Study 11398549 — intervention group
Group type: EXPERIMENTAL
Intervention: Bass appliance
Number of subjects: 42
Study 11398549 — intervention group
Group type: COMPARATOR
Intervention: Twin Block (TB)
Number of subjects: 42
Study 11398549 — intervention group
Group type: COMPARATOR
Intervention: Twin Block + Headgear (TB + Hg)
Number of subjects: 42
Study 9427988 — intervention group
Group type: EXPERIMENTAL
Intervention: Echothiophate iodide eyedrops once daily for 4 months
Number of subjects: 41
Study 9427988 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone eyedrops for 1 week after surgery
Number of subjects: 41
Study 8387885 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperfractionated radiation therapy (HFX RT) to a total tumor dose of 64.80 Gy (treatment arm 1)
Number of subjects: 169
Study 8387885 — intervention group
Group type: EXPERIMENTAL
Intervention: HFX RT to the same tumor dose with chemotherapy (CT) consisting of 100 mg of carboplatin, days 1 and 2, and 100 mg of etoposide (VP‐16), days 1‐3 (treatment arm 2)
Number of subjects: 169
Study 8387885 — intervention group
Group type: EXPERIMENTAL
Intervention: HFX RT to the same tumor dose with CT consisting of 200 mg of CBCDA, days 1 and 2, and 100 mg of VP‐16, days 1‐5 (treatment arm 3)
Number of subjects: 169
Study 3687518 — intervention group
Group type: EXPERIMENTAL
Intervention: Interaction of dietary restraint and depression
Number of subjects: 73
Study 3687518 — intervention group
Group type: EXPERIMENTAL
Intervention: Interaction of dietary restraint and biphasic mood shifts
Number of subjects: 73
Study 31238343 — intervention group
Group type: EXPERIMENTAL
Intervention: Partially Hydrolyzed Formula (PHF)
Number of subjects: 110
Study 31238343 — intervention group
Group type: COMPARATOR
Intervention: Standard Formula (SF)
Number of subjects: 110
Study 29713086 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin
Number of subjects: 376
Study 29713086 — intervention group
Group type: COMPARATOR
Intervention: Docetaxel
Number of subjects: 376
Study 27760995 — intervention group
Group type: EXPERIMENTAL
Intervention: L-tryptophan
Number of subjects: 20
Study 27760995 — intervention group
Group type: EXPERIMENTAL
Intervention: L-leucine
Number of subjects: 20
Study 27760995 — intervention group
Group type: COMPARATOR
Intervention: Glucose and water
Number of subjects: 20
Study 25911631 — intervention group
Group type: EXPERIMENTAL
Intervention: REHLOW (250 g carbohydrates in 400 mL of water)
Number of subjects: 9
Study 25911631 — intervention group
Group type: EXPERIMENTAL
Intervention: REHFULL (same syrup plus water to match fluid losses, 3170 ± 190 mL)
Number of subjects: 9
Study 25911631 — intervention group
Group type: COMPARATOR
Intervention: Comparison of REHLOW and REHFULL
Number of subjects: 9
Study 23294032 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous immunoglobulin (SCIG)
Number of subjects: 30
Study 23294032 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous saline (control)
Number of subjects: 30
Study 21500927 — intervention group
Group type: EXPERIMENTAL
Intervention: Full attention during training and testing
Number of subjects: 180
Study 21500927 — intervention group
Group type: COMPARATOR
Intervention: Concurrent cognitive load during training and testing
Number of subjects: 180
Study 21500927 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent cognitive load during training
Number of subjects: 180
Study 17200103 — intervention group
Group type: EXPERIMENTAL
Intervention: Faith-based weight-loss intervention (treatment group)
Number of subjects: 73
Study 17200103 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 73
Study 16734311 — intervention group
Group type: EXPERIMENTAL
Intervention: Compoglass
Number of subjects: 57
Study 16734311 — intervention group
Group type: COMPARATOR
Intervention: FluroShield
Number of subjects: 57
Study 14630377 — intervention group
Group type: EXPERIMENTAL
Intervention: Stroke information packet
Number of subjects: 177
Study 14630377 — intervention group
Group type: COMPARATOR
Intervention: Control packet on colorectal cancer
Number of subjects: 177
Study 11106204 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 40 mg o.d. for 8 weeks
Number of subjects: 29
Study 11106204 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 8 weeks
Number of subjects: 29
Study 11106204 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 40 mg o.d. after placebo
Number of subjects: 29
Study 11106204 — intervention group
Group type: COMPARATOR
Intervention: Placebo after omeprazole
Number of subjects: 29
Study 7860820 — intervention group
Group type: EXPERIMENTAL
Intervention: Film and vibration
Number of subjects: 145
Study 7860820 — intervention group
Group type: COMPARATOR
Intervention: Vibration
Number of subjects: 145
Study 7860820 — intervention group
Group type: COMPARATOR
Intervention: Film
Number of subjects: 145
Study 2571726 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertensive patients
Number of subjects: 60
Study 2571726 — intervention group
Group type: COMPARATOR
Intervention: Normotensive subjects
Number of subjects: 60
Study 2571726 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients taking beta-blocker medication
Number of subjects: 60
Study 1056801 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG
Number of subjects: 0
Study 1056801 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy (biweekly methotrexate and monthly prednisone and vincristine)
Number of subjects: 0
Study 1056801 — intervention group
Group type: COMPARATOR
Intervention: No therapy
Number of subjects: 0
Study 31482970 — intervention group
Group type: EXPERIMENTAL
Intervention: Tannin extract of Acacia mangium at 1% concentration
Number of subjects: 0
Study 31482970 — intervention group
Group type: EXPERIMENTAL
Intervention: Tannin extract of Myristica fragrans at 1% concentration
Number of subjects: 0
Study 31482970 — intervention group
Group type: EXPERIMENTAL
Intervention: Tannin extract of Acacia villosa at 1% concentration
Number of subjects: 0
Study 31482970 — intervention group
Group type: EXPERIMENTAL
Intervention: Tannin extract of Calliandra calothyrsus at 1% concentration
Number of subjects: 0
Study 30665606 — intervention group
Group type: EXPERIMENTAL
Intervention: four-session web-based intervention (Partners Connect)
Number of subjects: 234
Study 30665606 — intervention group
Group type: COMPARATOR
Intervention: waitlist control group
Number of subjects: 234
Study 28431010 — intervention group
Group type: EXPERIMENTAL
Intervention: BMS-936559 (0.3 mg/kg)
Number of subjects: 8
Study 28431010 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 26138674 — intervention group
Group type: EXPERIMENTAL
Intervention: DCM applied since 2009 (Group A)
Number of subjects: 0
Study 26138674 — intervention group
Group type: EXPERIMENTAL
Intervention: DCM newly introduced during the study (Group B)
Number of subjects: 0
Study 26138674 — intervention group
Group type: COMPARATOR
Intervention: Control intervention based on regular and standardized QoL rating (Group C)
Number of subjects: 0
Study 24418949 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic interactive SSE educational intervention
Number of subjects: 500
Study 24418949 — intervention group
Group type: COMPARATOR
Intervention: Workbook intervention
Number of subjects: 500
Study 24418949 — intervention group
Group type: COMPARATOR
Intervention: In-person intervention
Number of subjects: 500
Study 24418949 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic interactive intervention
Number of subjects: 500
Study 22938002 — intervention group
Group type: EXPERIMENTAL
Intervention: Extreme day cream (EXD)
Number of subjects: 0
Study 22938002 — intervention group
Group type: EXPERIMENTAL
Intervention: Extreme night treatment (EXN)
Number of subjects: 0